On March 3, 2025, Eton Pharmaceuticals announced the launch of Galzin (zinc acetate) capsules, the only FDA-approved zinc therapy for Wilson disease, now available through Optime Care. The Eton Cares Program will also be administered in partnership with Optime Care.